Abstract
Engraftment syndrome (ES) is a known complication of autologous hematopoietic stem cell transplant during neutrophil recovery. There is a limited amount of data available comparing the incidence of ES with post-transplant granulocyte colony-stimulating factor versus granulocyte macrophage colony-stimulating factor (GM-CSF), specifically in patients with multiple myeloma. Our retrospective review of 156 patients at a single center showed that GM-CSF was associated with a higher incidence of ES compared with G-CSF (32% versus 8% of patients, P < .001) and that development of ES was associated with a 32.9% (P < .001) longer hospital stay. This suggests that the choice of growth factor could possibly contribute to the development of ES and the associated costs of increased medical care.
| Original language | English |
|---|---|
| Pages (from-to) | e293-e297 |
| Journal | Biology of Blood and Marrow Transplantation |
| Volume | 25 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 2019 |
Keywords
- Autologous
- Engraftment syndrome
- Growth factor
- Multiple myeloma
- Stem cell transplant
Fingerprint
Dive into the research topics of 'Autologous Stem Cell Transplantation for Multiple Myeloma: Growth Factor Matters'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver